Trevi Therapeutics, Inc. TRVI Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s cash provided by (used in) investing activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s cash provided by (used in) investing activity, including discontinued operation?
- Trevi Therapeutics, Inc. (TRVI) reported cash provided by (used in) investing activity, including discontinued operation of $16.97M in Q1 2026.
- How has Trevi Therapeutics, Inc.'s cash provided by (used in) investing activity, including discontinued operation changed year-over-year?
- Trevi Therapeutics, Inc.'s cash provided by (used in) investing activity, including discontinued operation increased by 270.5% year-over-year, from -$9.95M to $16.97M.
- What does cash provided by (used in) investing activity, including discontinued operation mean?
- The total net cash flow resulting from all investing activities, including capital expenditures, acquisitions, and the purchase or sale of securities. It serves as a primary indicator of how much capital the company is reinvesting into its long-term growth and asset base.